[1]
“Comparative clinical effectiveness of generic and original apixaban in anticoagulant therapy for patients with arterial hypertension and permanent atrial fibrillation”, Je, vol. 1, no. 2, pp. 112–121, Jun. 2024, doi: 10.70626/3060-4850-2024-1-2-133-142.